Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2025-10-17 00:00:00 ET · period of report 2025-10-15 · accession 0001196632-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-17 | 2025-10-15 | EBS | LINDAHL RICHARD S | EVP, CFO | F - Tax | $9.60 | -4,995 | 291.5K | -2% | -$48.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-15 | F | D | 4,995 | $9.60 | 291,497 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units. |